Meningococcal Vaccines Market Research Report By Vaccine Type (Monovalent Vaccines, Multivalent Vaccines, Conjugate Vaccines), By Age Group (Infants, Children, Adolescents, Adults), By Administration Route (Intramuscular, Subcutaneous, Oral), By Distribution Channel (Hospitals, Clinics, Pharmacies) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

1.1. Market Overview

1.2. Key Findings

1.3. Market Segmentation

1.4. Competitive Landscape

1.5. Challenges and Opportunities

1.6. Future Outlook

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the study

2.2.1. Research Objective

2.2.2. Assumption

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value chain Analysis

5.2. Porter's Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. MENINGOCOCCAL VACCINES MARKET, BY VACCINE TYPE (USD BILLION)

6.1. Monovalent Vaccines

6.2. Multivalent Vaccines

6.3. Conjugate Vaccines

7. MENINGOCOCCAL VACCINES MARKET, BY AGE GROUP (USD BILLION)

7.1. Infants

7.2. Children

7.3. Adolescents

7.4. Adults

8. MENINGOCOCCAL VACCINES MARKET, BY ADMINISTRATION ROUTE (USD BILLION)

8.1. Intramuscular

8.2. Subcutaneous

8.3. Oral

9. MENINGOCOCCAL VACCINES MARKET, BY DISTRIBUTION CHANNEL (USD BILLION)

9.1. Hospitals

9.2. Clinics

9.3. Pharmacies

10. MENINGOCOCCAL VACCINES MARKET, BY REGIONAL (USD BILLION)

10.1. North America

10.1.1. US

10.1.2. Canada

10.2. Europe

10.2.1. Germany

10.2.2. UK

10.2.3. France

10.2.4. Russia

10.2.5. Italy

10.2.6. Spain

10.2.7. Rest of Europe

10.3. APAC

10.3.1. China

10.3.2. India

10.3.3. Japan

10.3.4. South Korea

10.3.5. Malaysia

10.3.6. Thailand

10.3.7. Indonesia

10.3.8. Rest of APAC

10.4. South America

10.4.1. Brazil

10.4.2. Mexico

10.4.3. Argentina

10.4.4. Rest of South America

10.5. MEA

10.5.1. GCC Countries

10.5.2. South Africa

10.5.3. Rest of MEA

11. COMPETITIVE LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market share Analysis

11.4. Major Growth Strategy in the Meningococcal Vaccines Market

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of Number of Developments in the Meningococcal Vaccines Market

11.7. Key developments and growth strategies

11.7.1. New Product Launch/Service Deployment

11.7.2. Merger & Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix

11.8.1. Sales and Operating Income

11.8.2. Major Players R&D Expenditure. 2023

12. COMPANY PROFILES

12.1. Emergent BioSolutions

12.1.1. Financial Overview

12.1.2. Products Offered

12.1.3. Key Developments

12.1.4. SWOT Analysis

12.1.5. Key Strategies

12.2. Sanofi

12.2.1. Financial Overview

12.2.2. Products Offered

12.2.3. Key Developments

12.2.4. SWOT Analysis

12.2.5. Key Strategies

12.3. Astellas Pharma

12.3.1. Financial Overview

12.3.2. Products Offered

12.3.3. Key Developments

12.3.4. SWOT Analysis

12.3.5. Key Strategies

12.4. MassBiologics

12.4.1. Financial Overview

12.4.2. Products Offered

12.4.3. Key Developments

12.4.4. SWOT Analysis

12.4.5. Key Strategies

12.5. Serum Institute of India

12.5.1. Financial Overview

12.5.2. Products Offered

12.5.3. Key Developments

12.5.4. SWOT Analysis

12.5.5. Key Strategies

12.6. Hikma Pharmaceuticals

12.6.1. Financial Overview

12.6.2. Products Offered

12.6.3. Key Developments

12.6.4. SWOT Analysis

12.6.5. Key Strategies

12.7. Baxter International

12.7.1. Financial Overview

12.7.2. Products Offered

12.7.3. Key Developments

12.7.4. SWOT Analysis

12.7.5. Key Strategies

12.8. GlaxoSmithKline

12.8.1. Financial Overview

12.8.2. Products Offered

12.8.3. Key Developments

12.8.4. SWOT Analysis

12.8.5. Key Strategies

12.9. Valneva

12.9.1. Financial Overview

12.9.2. Products Offered

12.9.3. Key Developments

12.9.4. SWOT Analysis

12.9.5. Key Strategies

12.10. Pfizer

12.10.1. Financial Overview

12.10.2. Products Offered

12.10.3. Key Developments

12.10.4. SWOT Analysis

12.10.5. Key Strategies

12.11. Biomedal

12.11.1. Financial Overview

12.11.2. Products Offered

12.11.3. Key Developments

12.11.4. SWOT Analysis

12.11.5. Key Strategies

12.12. ZyCoVD

12.12.1. Financial Overview

12.12.2. Products Offered

12.12.3. Key Developments

12.12.4. SWOT Analysis

12.12.5. Key Strategies

12.13. Merck and Co

12.13.1. Financial Overview

12.13.2. Products Offered

12.13.3. Key Developments

12.13.4. SWOT Analysis

12.13.5. Key Strategies

12.14. Novartis

12.14.1. Financial Overview

12.14.2. Products Offered

12.14.3. Key Developments

12.14.4. SWOT Analysis

12.14.5. Key Strategies

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1. LIST OF ASSUMPTIONS

TABLE 2. NORTH AMERICA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 3. NORTH AMERICA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 4. NORTH AMERICA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 5. NORTH AMERICA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 6. NORTH AMERICA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 7. US MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 8. US MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 9. US MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 10. US MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 11. US MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 12. CANADA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 13. CANADA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 14. CANADA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 15. CANADA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 16. CANADA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 17. EUROPE MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 18. EUROPE MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 19. EUROPE MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 20. EUROPE MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 21. EUROPE MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 22. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 23. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 24. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 25. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 26. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 27. UK MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 28. UK MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 29. UK MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 30. UK MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 31. UK MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 32. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 33. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 34. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 35. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 36. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 37. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 38. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 39. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 40. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 41. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 42. ITALY MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 43. ITALY MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 44. ITALY MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 45. ITALY MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 46. ITALY MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 47. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 48. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 49. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 50. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 51. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 52. REST OF EUROPE MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 53. REST OF EUROPE MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 54. REST OF EUROPE MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 55. REST OF EUROPE MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 56. REST OF EUROPE MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 57. APAC MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 58. APAC MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 59. APAC MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 60. APAC MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 61. APAC MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 62. CHINA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 63. CHINA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 64. CHINA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 65. CHINA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 66. CHINA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 67. INDIA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 68. INDIA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 69. INDIA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 70. INDIA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 71. INDIA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 72. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 73. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 74. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 75. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 76. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 77. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 78. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 79. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 80. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 81. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 82. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 83. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 84. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 85. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 86. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 87. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 88. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 89. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 90. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 91. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 92. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 93. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 94. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 95. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 96. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 97. REST OF APAC MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 98. REST OF APAC MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 99. REST OF APAC MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 100. REST OF APAC MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 101. REST OF APAC MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 102. SOUTH AMERICA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 103. SOUTH AMERICA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 104. SOUTH AMERICA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 105. SOUTH AMERICA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 106. SOUTH AMERICA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 107. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 108. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 109. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 110. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 111. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 112. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 113. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 114. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 115. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 116. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 117. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 118. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 119. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 120. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 121. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 122. REST OF SOUTH AMERICA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 123. REST OF SOUTH AMERICA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 124. REST OF SOUTH AMERICA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 125. REST OF SOUTH AMERICA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 126. REST OF SOUTH AMERICA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 127. MEA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 128. MEA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 129. MEA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 130. MEA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 131. MEA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 132. GCC COUNTRIES MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 133. GCC COUNTRIES MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 134. GCC COUNTRIES MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 135. GCC COUNTRIES MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 136. GCC COUNTRIES MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 137. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 138. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 139. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 140. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 141. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 142. REST OF MEA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)

TABLE 143. REST OF MEA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2032 (USD BILLIONS)

TABLE 144. REST OF MEA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)

TABLE 145. REST OF MEA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)

TABLE 146. REST OF MEA MENINGOCOCCAL VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL

TABLE 148. ACQUISITION/PARTNERSHIP

LIST OF FIGURES

FIGURE 1. MARKET SYNOPSIS

FIGURE 2. NORTH AMERICA MENINGOCOCCAL VACCINES MARKET ANALYSIS

FIGURE 3. US MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 4. US MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 5. US MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 6. US MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 7. US MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 8. CANADA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 9. CANADA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 10. CANADA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 11. CANADA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 12. CANADA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 13. EUROPE MENINGOCOCCAL VACCINES MARKET ANALYSIS

FIGURE 14. GERMANY MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 15. GERMANY MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 16. GERMANY MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 17. GERMANY MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 18. GERMANY MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 19. UK MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 20. UK MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 21. UK MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 22. UK MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 23. UK MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 24. FRANCE MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 25. FRANCE MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 26. FRANCE MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 27. FRANCE MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 28. FRANCE MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 29. RUSSIA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 30. RUSSIA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 31. RUSSIA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 32. RUSSIA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 33. RUSSIA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 34. ITALY MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 35. ITALY MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 36. ITALY MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 37. ITALY MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 38. ITALY MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 39. SPAIN MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 40. SPAIN MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 41. SPAIN MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 42. SPAIN MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 43. SPAIN MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 44. REST OF EUROPE MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 45. REST OF EUROPE MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 46. REST OF EUROPE MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 47. REST OF EUROPE MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 48. REST OF EUROPE MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 49. APAC MENINGOCOCCAL VACCINES MARKET ANALYSIS

FIGURE 50. CHINA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 51. CHINA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 52. CHINA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 53. CHINA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 54. CHINA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 55. INDIA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 56. INDIA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 57. INDIA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 58. INDIA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 59. INDIA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 60. JAPAN MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 61. JAPAN MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 62. JAPAN MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 63. JAPAN MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 64. JAPAN MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 65. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 66. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 67. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 68. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 69. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 70. MALAYSIA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 71. MALAYSIA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 72. MALAYSIA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 73. MALAYSIA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 74. MALAYSIA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 75. THAILAND MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 76. THAILAND MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 77. THAILAND MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 78. THAILAND MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 79. THAILAND MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 80. INDONESIA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 81. INDONESIA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 82. INDONESIA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 83. INDONESIA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 84. INDONESIA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 85. REST OF APAC MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 86. REST OF APAC MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 87. REST OF APAC MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 88. REST OF APAC MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 89. REST OF APAC MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 90. SOUTH AMERICA MENINGOCOCCAL VACCINES MARKET ANALYSIS

FIGURE 91. BRAZIL MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 92. BRAZIL MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 93. BRAZIL MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 94. BRAZIL MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 95. BRAZIL MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 96. MEXICO MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 97. MEXICO MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 98. MEXICO MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 99. MEXICO MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 100. MEXICO MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 101. ARGENTINA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 102. ARGENTINA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 103. ARGENTINA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 104. ARGENTINA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 105. ARGENTINA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 106. REST OF SOUTH AMERICA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 107. REST OF SOUTH AMERICA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 108. REST OF SOUTH AMERICA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 109. REST OF SOUTH AMERICA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 110. REST OF SOUTH AMERICA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 111. MEA MENINGOCOCCAL VACCINES MARKET ANALYSIS

FIGURE 112. GCC COUNTRIES MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 113. GCC COUNTRIES MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 114. GCC COUNTRIES MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 115. GCC COUNTRIES MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 116. GCC COUNTRIES MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 117. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 118. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 119. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 120. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 121. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 122. REST OF MEA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY VACCINE TYPE

FIGURE 123. REST OF MEA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY AGE GROUP

FIGURE 124. REST OF MEA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE

FIGURE 125. REST OF MEA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 126. REST OF MEA MENINGOCOCCAL VACCINES MARKET ANALYSIS BY REGIONAL

FIGURE 127. KEY BUYING CRITERIA OF MENINGOCOCCAL VACCINES MARKET

FIGURE 128. RESEARCH PROCESS OF MRFR

FIGURE 129. DRO ANALYSIS OF MENINGOCOCCAL VACCINES MARKET

FIGURE 130. DRIVERS IMPACT ANALYSIS: MENINGOCOCCAL VACCINES MARKET

FIGURE 131. RESTRAINTS IMPACT ANALYSIS: MENINGOCOCCAL VACCINES MARKET

FIGURE 132. SUPPLY / VALUE CHAIN: MENINGOCOCCAL VACCINES MARKET

FIGURE 133. MENINGOCOCCAL VACCINES MARKET, BY VACCINE TYPE, 2024 (% SHARE)

FIGURE 134. MENINGOCOCCAL VACCINES MARKET, BY VACCINE TYPE, 2019 TO 2032 (USD Billions)

FIGURE 135. MENINGOCOCCAL VACCINES MARKET, BY AGE GROUP, 2024 (% SHARE)

FIGURE 136. MENINGOCOCCAL VACCINES MARKET, BY AGE GROUP, 2019 TO 2032 (USD Billions)

FIGURE 137. MENINGOCOCCAL VACCINES MARKET, BY ADMINISTRATION ROUTE, 2024 (% SHARE)

FIGURE 138. MENINGOCOCCAL VACCINES MARKET, BY ADMINISTRATION ROUTE, 2019 TO 2032 (USD Billions)

FIGURE 139. MENINGOCOCCAL VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)

FIGURE 140. MENINGOCOCCAL VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019 TO 2032 (USD Billions)

FIGURE 141. MENINGOCOCCAL VACCINES MARKET, BY REGIONAL, 2024 (% SHARE)

FIGURE 142. MENINGOCOCCAL VACCINES MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)

FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS